Table 3.

Subgroup analyses: Adjusted risk of death in transplant recipients compared with patients who remained on dialysis

SubgroupHazard Ratio for Transplant within Subgroup (95% CI)
All patients0.60 (0.53 to 0.68)
Age, yr
 <400.44 (0.32 to 0.61)
 40–490.49 (0.38 to 0.63)
 50–590.49 (0.39 to 0.61)
 60–640.52 (0.38 to 0.70)
 65–690.60 (0.40 to 0.91)
Women0.38 (0.31 to 0.46)
Men0.58 (0.50 to 0.68)
Race
 White non-Hispanic0.51 (0.39 to 0.67)
 White Hispanic0.46 (0.34 to 0.62)
 Black0.46 (0.34 to 0.63)
Diabetes as cause of kidney failure0.73 (0.58 to 0.93)
Other causes0.56 (0.49 to 0.65)
Panel reactive antibody, %
 00.61 (0.49 to 0.75)
 1–790.60 (0.49 to 0.72)
 80–890.74 (0.42 to 1.32)
 90–980.96 (0.60 to 1.52)
 99–1000.60 (0.53 to 0.68)
Expected post-transplant survival, %
 1–200.49 (0.35 to 0.67)
 21–400.51 (0.39 to 0.65)
 41–600.69 (0.53 to 0.90)
 61–800.60 (0.46 to 0.78)
 81–1000.75 (0.58 to 0.97)
  • Multivariate model adjusted for differences in patient age, sex, race, cause of kidney disease, body mass index in kilograms per meter2, comorbid conditions, sensitization, and year of first chronic dialysis treatment. 95% CI, 95% confidence interval.